A Guide to Combination Therapies: Are IgG Cleaving Enzymes Alone Enough for AAV Gene Therapy Transfer?
Time: 1:30 pm
day: Day 1 Track B PM
- Introduction to methods to reduce humoral immune response to AAVs
- Limitations in the use of IdeS in a clinical setting
- Overcoming IdeS limitations through the use of combination therapies